Leptospiral nephropathy.
Sitprija V, Losuwanrak K, Kanjanabuch T.
Semin Nephrol. 2003 Jan;23(1):42-8. doi: 10.1053/snep.2003.50004.
[Drug nephrotoxicity].
Izzedine H.
Nephrol Ther. 2018 May;14(3):127-134. doi: 10.1016/j.nephro.2017.06.006. Epub 2018 Mar 11.
Nephrogenic adenoma.
Amin W, Parwani AV.
Pathol Res Pract. 2010 Oct 15;206(10):659-62. doi: 10.1016/j.prp.2010.06.001. Epub 2010 Jul 8.
Subnuclear renal tubular vacuoles in alcohol use disorder.
Auld FM, Parai JL, Milroy CM.
J Forensic Sci. 2023 Sep;68(5):1759-1767. doi: 10.1111/1556-4029.15321. Epub 2023 Jul 6.
Tubular lipidosis: epiphenomenon or pathogenetic lesion in human renal disease?
Ong AC, Moorhead JF.
Kidney Int. 1994 Mar;45(3):753-62. doi: 10.1038/ki.1994.100.
The Emerging Role of Renal Tubular Epithelial Cells in the Immunological Pathophysiology of Lupus Nephritis.
Hong S, Healy H, Kassianos AJ.
Front Immunol. 2020 Sep 23;11:578952. doi: 10.3389/fimmu.2020.578952. eCollection 2020.
Transient renal dysfunction with reversible splenial lesion.
Watanabe T, Matsuda T, Kitagata R, Tajima I, Ono H, Hirano K, Shirai M, Endoh A, Hongo T.
Pediatr Int. 2014 Oct;56(5):e68-71. doi: 10.1111/ped.12412.
Clinicopathologic Features of IgG4-Related Kidney Disease.
Buglioni A, Jenkins SM, Nasr SH, Zhang P, Gibson IW, Alexander MP, Herrera Hernandez LP, Fidler ME, Takahashi N, Hogan MC, Cornell LD.
Kidney Int Rep. 2024 May 15;9(8):2462-2473. doi: 10.1016/j.ekir.2024.05.011. eCollection 2024 Aug.
The glomerulo-tubular junction: a target in renal diseases.
Lindop GB, Gibson IW, Downie TT, Vass D, Cohen EP.
J Pathol. 2002 May;197(1):1-3. doi: 10.1002/path.1087.
The role of CDX2 in renal tubular lesions during diabetic kidney disease.
Liu H, Yan R, Liang L, Zhang H, Xiang J, Liu L, Zhang X, Mao Y, Peng W, Xiao Y, Zhang F, Zhou Y, Shi M, Wang Y, Guo B.
Aging (Albany NY). 2021 Feb 17;13(5):6782-6803. doi: 10.18632/aging.202537. Epub 2021 Feb 17.
